| ²é¿´: 1110 | »Ø¸´: 2 | |||
a116542ͳæ (³õÈëÎÄ̳)
|
[ÇóÖú]
ÇëÎʱûÏ©ëæÔÚÒ©ÎïÖк¬Á¿ÏÞ¶ÈÊǶàÉÙ£¿ ÒÑÓÐ1È˲ÎÓë
|
ËÓÐÏà¹Ø×ÊÁÏ£¬°ï棬Íò·Ö¸Ðл![]() |
» ²ÂÄãϲ»¶
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ223È˻ظ´
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
Éú·À¾úµÄÅèÔÔ·ÀЧʵÑé
ÒѾÓÐ1È˻ظ´
Çë½Ì´óÀÐÀ©É¢ÎÊÌâ
ÒѾÓÐ5È˻ظ´
¹òÇóÒ»Ö§AAV293ϸ°û
ÒѾÓÐ1È˻ظ´
ÖÐÎÄͶ¸å¡°Ö×ÁöÃâÒß¡±Ïà¹Ø
ÒѾÓÐ6È˻ظ´
2025ÄêҩѧרҵÇóµ÷¼Á
ÒѾÓÐ1È˻ظ´
292ҩѧµ÷¼Á
ÒѾÓÐ1È˻ظ´
jasonscott
Ìú³æ (ÕýʽдÊÖ)
- DRDEPI: 3
- Ó¦Öú: 65 (³õÖÐÉú)
- ½ð±Ò: 2573
- ºì»¨: 9
- Ìû×Ó: 533
- ÔÚÏß: 285.5Сʱ
- ³æºÅ: 809179
- ×¢²á: 2009-07-15
- רҵ: ÓлúºÏ³É
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
|
¸ù¾ÝADDENDUM TO ICH M7: ASSESSMENT AND CONTROL OF DNA REACTIVE (MUTAGENIC) IMPURITIES IN PHARMACEUTICALS TO LIMIT POTENTIAL CARCINOGENIC RISK APPLICATION OF THE PRINCIPLES OF THE ICH M7 GUIDELINE TO CALCULATION OF COMPOUND-SPECIFIC ACCEPTABLE INTAKES M7(R1)¹«¿ªµÄ¶¾ÀíÊý¾Ý£¬±ûÏ©ëæµÄPDEÊÇ6΢¿Ë/ÈÕ¡£Äã¸ù¾ÝÒ©ÎïµÄÈÕ·þÓüÁÁ¿À´ÍÆËãÔÊÐíÏ޶Ȱɡ£ |
2Â¥2016-05-27 15:56:54
a116542
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 42.6
- Ìû×Ó: 21
- ÔÚÏß: 21.6Сʱ
- ³æºÅ: 2025707
- ×¢²á: 2012-09-24
- רҵ: ·ÖÎöÒÇÆ÷ÓëÊÔ¼Á
3Â¥2016-05-30 11:36:06














»Ø¸´´ËÂ¥